Tuesday, October 07, 2014 8:20:33 PM
Blaming the 20% decline on DRIOD's share price on a 1.6% weakness in the Dow Jones index ?
Really?
I fail to see the correlation, as DRIOD is a mere OTC stock that 90% of it's share holder base was incapable of trading due to the ticker change.
Let me ask you this.
If DRIOD loses support at the .48 then .465 then .44 levels, what will most technicians suggest doing with the shares?
It's a relatively easy question.
Oh, and I have the answer.
I Just wanted to hear yours.
Really?
I fail to see the correlation, as DRIOD is a mere OTC stock that 90% of it's share holder base was incapable of trading due to the ticker change.
Let me ask you this.
If DRIOD loses support at the .48 then .465 then .44 levels, what will most technicians suggest doing with the shares?
It's a relatively easy question.
Oh, and I have the answer.
I Just wanted to hear yours.
Recent DRIO News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/30/2026 10:14:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/30/2026 04:15:17 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/19/2026 09:03:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/19/2026 09:02:06 PM
- DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results • PR Newswire (US) • 03/19/2026 10:30:00 AM
- DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026 • PR Newswire (US) • 03/11/2026 12:30:00 PM
- Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health • PR Newswire (US) • 03/10/2026 12:00:00 PM
- Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management • PR Newswire (US) • 03/03/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 09:32:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2026 09:06:11 PM
- Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms • PR Newswire (US) • 01/21/2026 01:00:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/29/2025 09:05:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/22/2025 09:12:29 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/16/2025 10:08:50 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/11/2025 10:15:51 PM
- Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members • PR Newswire (US) • 12/10/2025 01:00:00 PM
- Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio • PR Newswire (US) • 12/04/2025 01:00:00 PM
- DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year • PR Newswire (US) • 11/24/2025 01:00:00 PM
- DarioHealth Reports Third Quarter 2025 Financial and Operating Results • PR Newswire (US) • 11/13/2025 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 11:05:53 AM
- DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform • PR Newswire (US) • 11/12/2025 01:30:00 PM
